Fresenius Kabi USA, LLC recalls Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC,…
- Recall date
- April 25, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1037-2016
- FDA classification
- Class II
- Brand / firm
- Fresenius Kabi USA, LLC
- Sold / distributed
- Nationwide
Why it was recalled
Presence of Particulate Matter: Glass particulate found in sterile injectable product
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37
Get recall alerts
Free email alert whenever Fresenius Kabi USA, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi USA, LLC